TABLE 2.
DChol (nmol/mg protein) |
Ratio in Cholesterol-Rich/Cholesterol-Poor Microdomains | % Chol Replaced by DChol |
|||
---|---|---|---|---|---|
Incubation with DChol (h) | Cholesterol-Rich Microdomains | Cholesterol-Poor Microdomains | Cholesterol-Rich Microdomains | Cholesterol-Poor Microdomains | |
0.25 | 2.06 ± 0.69 | 0.98 ± 0.58 | 2.10 ± 0.84 | 0.21 ± 0.07 | 0.25 ± 0.15 |
1 | 4.52 ± 0.90 | 4.53 ± 0.18 | 0.99 ± 0.16 | 0.46 ± 0.09 | 1.16 ± 0.05 |
24 | 7.10 ± 0.65 | 9.37 ± 0.25 | 0.76 ± 0.04 | 0.72 ± 0.05 | 2.4 ± 0.06 |
L-cells were incubated with DChol-MβCD complex (20 μg/ml medium) for the indicated times as described in Methods. Cells were then fractionated to isolate plasma membranes, which were in turn resolved into cholesterol-rich and -poor microdomain enriched fractions by affinity chromatography, lipids were extracted, and DChol and cholesterol were quantitated as described in Methods. Values represent mean ± SEM of two experiments.